Yoshioka Sumie, Aso Yukio, Kojima Shigeo, Cappuccino Nicholas F
National Institute of Health Sciences, Setagaya, Tokyop, Japan.
Chem Pharm Bull (Tokyo). 2002 Jun;50(6):881-3. doi: 10.1248/cpb.50.881.
Stability data were generated by the Monte Carlo method, and batch-to-batch variability was evaluated by analysis of differences in slope and intercept according to the analysis of covariance (ANCOVA) approach recommended in the FDA Guidance. Using the same generated data, batch-to-batch variability was also evaluated by assessing the equivalence of shelf lives estimated for individual batches based on the range (Range-based approach) in order to compare the ability of the two approaches to detect stability differences among batches. The results of the study indicated that the Range-based approach can detect a 30% difference in the slope of degradation curves among batches with a similar beta error as the ANCOVA approach, provided that degradation data are obtained with assay errors below 0.5. The range-based approach appears to be useful as an alternative method to ANCOVA, if it is modified such that the variance of estimates is taken into account.
稳定性数据通过蒙特卡罗方法生成,批次间的变异性根据美国食品药品监督管理局指南中推荐的协方差分析(ANCOVA)方法,通过分析斜率和截距的差异来评估。使用相同的生成数据,还通过基于范围评估各个批次估计的货架期等效性(基于范围的方法)来评估批次间的变异性,以便比较两种方法检测批次间稳定性差异的能力。研究结果表明,如果降解数据的测定误差低于0.5,基于范围的方法在β误差与ANCOVA方法相似的情况下,能够检测出批次间降解曲线斜率30%的差异。如果对基于范围的方法进行修改以考虑估计的方差,它似乎可作为ANCOVA的替代方法。